HaemAnalytica
HaemAnalytica is a UK-based company revolutionizing drug development and clinical trials through next-generation platelet function testing technologies. Their multiparameter platelet function assays, including Absolute HaemAnalytics, Classic HaemAnalytics, and Rapid HaemAnalytics, enable deep phenotyping and patient stratification using AI-based analysis. These technologies facilitate multi-centre clinical trials, drug discovery, biomedical research, and diagnostics by providing precise, reproducible platelet function data without requiring extensive onsite expertise or equipment. HaemAnalytica's innovations help de-risk clinical trials, enhance drug development, and support personalized medicine by accurately assessing platelet function and reactivity. The company is led by a team of experienced executives and scientists with strong backgrounds in pharmaceutical, biotech, and platelet biology research.
HaemAnalytica
HaemAnalytica is a UK-based company revolutionizing drug development and clinical trials through next-generation platelet function testing technologies. Their multiparameter platelet function assays, including Absolute HaemAnalytics, Classic HaemAnalytics, and Rapid HaemAnalytics, enable deep phenotyping and patient stratification using AI-based analysis. These technologies facilitate multi-centre clinical trials, drug discovery, biomedical research, and diagnostics by providing precise, reproducible platelet function data without requiring extensive onsite expertise or equipment. HaemAnalytica's innovations help de-risk clinical trials, enhance drug development, and support personalized medicine by accurately assessing platelet function and reactivity. The company is led by a team of experienced executives and scientists with strong backgrounds in pharmaceutical, biotech, and platelet biology research.